Advocate for evidence-based changes to expert society positions and consensus guidelines for hereditary cancer risk assessment, genetic testing, and strategies for the prevention, early detection, and treatment of cancer.
INTERACT submits formal requests to the National Comprehensive Cancer Network (NCCN) and other professional societies in support of guidelines based on emerging research. Examples of such requests are available at Guideline Requests.
Develop and publish data demonstrating the clinical utility of genetic testing in oncology.
Work to improve access to clinically indicated hereditary cancer risk assessment and testing through increasing awareness, developing improved service models that effectively address disparities, and fostering appropriate payer policies that reflect professional group guidance for standards of clinical care.
